> top > docs > PMC:7502678 > spans > 8395-11918 > annotations

PMC:7502678 / 8395-11918 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T4 1025-1036 Body_part denotes vagus nerve http://purl.org/sig/ont/fma/fma5731

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T4 1025-1036 Body_part denotes vagus nerve http://purl.obolibrary.org/obo/UBERON_0001759
T5 1031-1036 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T42 762-765 Disease denotes CMS http://purl.obolibrary.org/obo/MONDO_0018940
T43 991-999 Disease denotes epilepsy http://purl.obolibrary.org/obo/MONDO_0005027
T44 1276-1284 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T45 1665-1673 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T46 1707-1716 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T47 2167-2175 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T48 2230-2238 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T49 2373-2376 Disease denotes ASM http://purl.obolibrary.org/obo/MONDO_0020333
T50 2408-2416 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T51 3064-3072 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T37 56-57 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T38 208-215 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T39 1031-1036 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T40 1312-1313 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T41 1752-1753 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T42 1763-1765 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T43 3189-3192 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T6 779-782 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T7 1892-1895 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T8 2071-2076 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T9 2207-2210 Chemical denotes EEG http://purl.obolibrary.org/obo/CHEBI_73494
T10 2582-2595 Chemical denotes levetiracetam http://purl.obolibrary.org/obo/CHEBI_6437
T11 2600-2609 Chemical denotes midazolam http://purl.obolibrary.org/obo/CHEBI_6931
T12 2642-2644 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T13 2645-2660 Chemical denotes benzodiazepines http://purl.obolibrary.org/obo/CHEBI_22720
T14 2962-2964 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
145 633-640 Species denotes patient Tax:9606
151 1018-1022 Species denotes EMUs Tax:8790
152 949-954 Disease denotes COVID MESH:C000657245
153 991-999 Disease denotes epilepsy MESH:D004827
154 1206-1211 Disease denotes COVID MESH:C000657245
155 1276-1284 Disease denotes COVID-19 MESH:C000657245
161 1626-1634 Species denotes patients Tax:9606
162 1968-1972 Species denotes EMUs Tax:8790
163 1665-1673 Disease denotes COVID-19 MESH:C000657245
164 1707-1716 Disease denotes infection MESH:D007239
165 2167-2175 Disease denotes COVID-19 MESH:C000657245
167 2230-2238 Disease denotes COVID-19 MESH:C000657245
174 2952-2960 Species denotes patients Tax:9606
175 2582-2595 Chemical denotes levetiracetam MESH:D000077287
176 2600-2609 Chemical denotes midazolam MESH:D008874
177 2645-2660 Chemical denotes benzodiazepines MESH:D001569
178 2352-2359 Disease denotes seizure MESH:D012640
179 2408-2416 Disease denotes COVID-19 MESH:C000657245
181 3064-3072 Disease denotes COVID-19 MESH:C000657245
183 3249-3256 Species denotes patient Tax:9606

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T34 991-999 Phenotype denotes epilepsy http://purl.obolibrary.org/obo/HP_0001250
T35 2352-2359 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T4 3404-3412 http://purl.obolibrary.org/obo/GO_0007612 denotes learning

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T74 0-27 Sentence denotes Impact on Clinical Practice
T75 29-55 Sentence denotes Barriers to Providing Care
T76 56-128 Sentence denotes A range of barriers were reported in providing care during the pandemic.
T77 129-269 Sentence denotes Most frequently noted were limited access to in-person visits and nonemergency testing reported by 74% and 66% of respondents, respectively.
T78 270-488 Sentence denotes Provider fear related to the outbreak and concern for their own well-being was reported by nearly 30%, while lack of personal protective equipment (PPE) and financial considerations were reported by 25% of respondents.
T79 489-572 Sentence denotes Technological problems for telehealth visits were noted in only 15% of respondents.
T80 573-666 Sentence denotes Only 7% of respondents experienced no barriers in providing patient care during the pandemic.
T81 667-837 Sentence denotes One respondent noted that between the pandemic and Centers for Medicare and Medicaid Services (CMS) cutbacks on EEG reimbursement, continuing practice appeared difficult.
T82 838-1213 Sentence denotes Respondents also cited the following additional practice-related barriers to providing care: prioritization of COVID over nonurgent care; suspensions of epilepsy monitoring units (EMUs), vagus nerve stimulator implantations, and presurgical evaluation and surgery; reopening logistics; staff cuts; and clinic staffing (eg, childcare challenges and fear of exposure to COVID).
T83 1214-1411 Sentence denotes Regarding when respondents expected to return services to pre-COVID-19 levels, the answers formed a normally distributed Bell-shaped curve between now and never, centered at approximately 6 months.
T84 1412-1449 Sentence denotes Only 9% of respondents were not sure.
T85 1450-1523 Sentence denotes Approximately 5% did not feel their practice would ever return to normal.
T86 1525-1553 Sentence denotes Neurophysiologic Evaluations
T87 1554-1717 Sentence denotes About half of respondents (47%) reported that EEGs were discouraged for patients admitted to the hospital with COVID-19 or those suspected of having the infection.
T88 1718-1829 Sentence denotes Even without restrictions, nearly a quarter (22%) reported they were doing fewer studies than usual (Figure 4).
T89 1830-1907 Sentence denotes About 9% responded they were no longer doing continuous video-EEG monitoring.
T90 1908-1984 Sentence denotes In the write in comments, many respondents noted that their EMUs had closed.
T91 1985-2185 Sentence denotes Very few respondents (2%) reported that they were doing more EEGs than usual; of this group, 5 were from institutions where there were no restrictions for performing EEGs during the COVID-19 pandemic.
T92 2186-2195 Sentence denotes Figure 4.
T93 2197-2248 Sentence denotes Inpatient EEG utilization during COVID-19 pandemic.
T94 2250-2286 Sentence denotes Medication Interactions or Shortages
T95 2287-2417 Sentence denotes Almost no respondents had seen unusual interactions between anti-seizure medications (ASM) and medications used to treat COVID-19.
T96 2418-2498 Sentence denotes Medications shortages were noted by approximately 44% of respondents (Figure 5).
T97 2499-2692 Sentence denotes In write-in comments, the most frequently noted shortages were of extended release levetiracetam and midazolam, and other shortages of several IV benzodiazepines were noted by some respondents.
T98 2693-2772 Sentence denotes However, it appears some of these shortages existed from prior to the pandemic.
T99 2773-2902 Sentence denotes By and large, there appeared to be no consistent pattern of shortages of conventional ASMs directly attributable to the pandemic.
T100 2903-3024 Sentence denotes The majority of shortage reports originated from patients; IV anesthetic shortages were reported by inpatient pharmacies.
T101 3025-3034 Sentence denotes Figure 5.
T102 3036-3082 Sentence denotes Medication shortages during COVID-19 pandemic.
T103 3084-3102 Sentence denotes Impact on Trainees
T104 3103-3229 Sentence denotes Trainees (residents and fellows) responded in low numbers and noted that the pandemic has harmed their educational experience.
T105 3230-3309 Sentence denotes They cited reduced patient volumes and canceled clinics as responsible factors.
T106 3310-3523 Sentence denotes Furthermore, the cancelling of interprofessional conferences and educational meetings limited learning and networking opportunities outside the home institution as well as the opportunity to present academic work.